Back to Search Start Over

How good is cost-benefit assessment of phase II cancer trials?

Authors :
Bradbury J
Source :
The Lancet. Oncology [Lancet Oncol] 2002 Sep; Vol. 3 (9), pp. 524.
Publication Year :
2002

Subjects

Subjects :
Cost-Benefit Analysis
Humans
Neoplasms therapy
Clinical Trials, Phase II as Topic economics

Details

Language :
English
ISSN :
1470-2045
Volume :
3
Issue :
9
Database :
MEDLINE
Journal :
The Lancet. Oncology
Publication Type :
Periodical
Accession number :
12217785
Full Text :
https://doi.org/10.1016/s1470-2045(02)00868-9
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details